2021-09-19-世界卫生组织-Weekly_operational_update_on_COVID-19_-_20_September_2021_16页_1mb

报告摘要

As of September 19, 2021, there were 227,940,972 confirmed COVID-19 cases and 4,682,899 deaths globally, with real-time trends accessible via the WHO Dashboard and Situation Reports.

Sri Lanka Vaccination Drive: WHO provided urgently needed syringes totaling 2 million, supporting vaccination efforts. Expert advice from Dr. Alaka Singh emphasized donor flexibility for responsive aid.
COVAX Updates: COVAX delivered over 286 million vaccine doses, with Gavi and UNICEF administering support for equitable distribution.
Training and Capacity Building: OpenWHO reported high engagement in COVID-19 response training (7,717 enrollments), including courses on Integrated Disease Surveillance and Response (IDSR) to strengthen regional health systems.

Afghanistan Airlifts: In coordination with Qatar and the UAE, WHO delivered critical medical supplies (e.g., insulin, COVID-19 tests) totaling 131 metric tonnes across six flights, aiding over 2.43 million people and supporting 19,000 surgeries. Continued shipments planned.
Ethiopia Support: WHO's Dubai Logistics Hub shipped the largest humanitarian cargo (85 metric tonnes) to Ethiopia, reinforcing food insecurity and outbreak response efforts.
Belarus Partnership: Collaborated with Germany to supply surgical masks (1.386 million, worth USD 435,204) to disabled children centers, promoting COVID-19 protection and psychosocial support.
Cambodia Strategy: Rebooted COVID-19 strategy with focus on transmission suppression, including measures like limiting 3Cs (closed spaces) and promoting "3 Dos" (mask-wearing, handwashing, distancing) amid rising cases.

Mini-cPIE Clinics: Peer-to-peer learning sessions conducted (13 reports submitted, 17 ongoing) to review and refine vaccination rollout strategies, sharing best practices like digital data tracking and community engagement.
Lab Quality Assessment: A global proficiency test involved 3,300 labs; 97.3% results were correct, ensuring reliable SARS-CoV-2 testing.

Global shipments as of September 16, 2021, included lab supplies (e.g., COVID-19 PCR tests) and PPE for regions: Africa (5 million tests), Americas, Eastern Mediterranean, Europe, and Southeast Asia.
Procured essential items like gloves, masks, and surgical kits, with ongoing coordination for ultra-cold chain vaccines.

SPRP 2021: Funded at USD 1.06 billion out of USD 1.96 billion target, with gaps in flexible funding affecting operational responsiveness.
Solidarity Fund: Over USD 254 million secured from more than 674,859 donors, supporting transmission suppression and equitable tool access.

Progress Indicators: Key metrics include 49% of southern hemisphere and tropical countries timely reporting COVID-19 data, and near-universal COVID-19 vaccination start across 194 countries.
Deadlines Extended: Applications for COVAX vaccine delivery support now closer, with readiness checklists open for Pfizer-BioNTech ultra-cold chain handling.